Patient Perspectives Roundtable

August 6th Roundtable

Focus on Survivorship/Quality of Life and Patient-Reported Outcomes
Friday, August 6, 2021
9:00 am CDT | 2:00 pm UTC

This 90-minute Virtual Patient Perspectives Roundtable, “Focus on Survivorship/Quality of Life and Patient-Reported Outcomes," is the third in a series of four roundtables sponsored by GSK.

These topics are relevant to patient overall survival, well-being/quality of life, care, and outcomes and cover patient assessments of their cancer experience, all in and beyond the backdrop of COVID-19 and of global discussions of health equity. Participating in this active exchange of information will enhance understanding of these important topics and empower attendees.

Moderator
Rosalind Glasspool, MD
IGCS Council Member
Medical Oncologist, National Health Service Greater Glasgow and Clyde
Scotland
 
Panelists
Raimundo Correa, MD
Gynecologic Oncologist
Palliative Care Sub-Specialist
Staff Physician, Hospital Santiago Oriente & Clinica Las Condes
Chile
 
Sally Kwenda
Patient Advocate
HIV/AIDS Counselor
Member, Noncommunicable Disease Alliance-Kenya
Global Hero of Hope
Kenya
 
Sharon Manne, PhD
Clinical Psychologist
Professor of Medicine
Chief of Behavioral Science
Founder & Co-Director of Center of Excellence in Cancer Survivorship
Rutgers Cancer Institute of New Jersey
USA
 
Eva-Maria Strömsholm, RN
Patient Advocate
Nurse/Teacher
Co-Founder & Vice-Chair, Gynecological Cancerpatients Finland
Member, Board of Cancer Society of Finland
Finland
Save the Date:
Global Health Equity: Conversation to Implementation
Friday, October 15, 2021
9:00 am CDT | 2:00 pm UTC

About the IGCS Patient Perspectives Roundtable Series
During the COVID-19 pandemic and in its aftermath, IGCS will continue to be a global source of education and resources, training, public awareness, and advocacy. Virtual Roundtables will

  • facilitate first-hand assessment of patient community needs and concerns
  • provide vetted information, assessments, and guidance from key opinion leaders and seasoned survivors/advocates
  • address current patient and wider community concerns through live responses to question posted online during the session
  • promote strategic conversations with health care and research communities around specific issues
  • assist all in coming to workable solutions and strategies for moving forward during the COVID-19 pandemic and in its aftermath

Each 60- to 90-minute session will cover a specific topic important to the gynecologic cancer patient communities maneuvering through the health and cancer care system during and after COVID-19 and will include IGCS key opinion leaders, patients-caregivers, and other stakeholders appropriate to the topic.

Previous Roundtables

Spotlight on Endometrial Cancer: Breakthroughs & Concerns
Recorded on May 14, 2021
Sponsored by GSK

Navigating Telehealth/Telemedicine & Embracing Shared Decision Making
Recorded November 21, 2020
Sponsored by GSK

Patient Advocacy & Support in the Backdrop of COVID-19
Recorded June 30, 2020

Gynecologic Cancer Patient Care & Clinical Trials in the Midst of COVID-19
Recorded May 23, 2020
Sponsored by GOG Foundation

Introducing IGCS COVID Safety Officer

Introducing IGCS COVID Safety Officer, Dr. Alessandro Cartelli

COVID-19 Health & Safety Guidelines and Requirements

  • Rapid testing is required for all delegates. Testing will be offered at the meeting venue on Sunday, August 29 and will remain available throughout the conference.
  • All meeting delegates must be tested by the IGCS COVID team and show a negative test result at the time of registration in order to enter the venue.

COVID-19 Health & Safety Guidelines and Requirements

  • Rapid testing is required for all delegates. Testing will be offered at the meeting venue on Sunday, August 29 and will remain available throughout the conference.
  • All meeting delegates must be tested by the IGCS COVID team and show a negative test result at the time of registration in order to enter the venue.
  • Face masks must be worn by all delegates at the congress while indoors as an extra safety precaution.
  • To accommodate social distancing at the Auditorium, a maximum of 500 in-person tickets will be sold. Seating within the halls has been spaced to adhere to social distance guidelines, currently 1m.
  • If a delegate tests positive for COVID-19, a molecular PCR test will be issued. If found positive, the delegate will not be allowed to enter the auditorium and will be advised on safe transportation from the auditorium to their hotel.

COVID-19 Health & Safety FAQ

Q: What Coronavirus-related safety precautions are being taken for meeting delegates in Rome?
A: IGCS is committed to the health and safety of our delegates, staff, and everyone who works at the meeting venue. We have been working closely with officials at the Auditorium, the local conference organizer, and receiving updates from the Italian government and we have implemented the following guidelines and procedures regarding COVID-19 safety.

Q: How many people will be able to attend in-person?
A: To accommodate social distancing at the Auditorium, a maximum of 500 in-person tickets will be sold.

Q: What is the COVID Safety Officer’s responsibility?
A: IGCS has appointed Dr. Alessandro Cartelli as COVID Safety Officer. He will be responsible for ensuring that guidelines are followed, and proper steps are taken in the event of a positive COVID case. For questions, please email Dr. Cartelli.

Q: What testing will be required to be admitted to the meeting venue?
A: Our onsite team will be conducting rapid testing with the STANDARD Q COVID-19 Ag Test by SD BIOSENSOR.  It is a rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in human nasopharynx, approved by the Italian and European FDA and is valid for the screening of this population. The specimen is collected though a nasopharyngeal swab. Test results will be available after 15 minutes and those who test negative will proceed to registration to collect their Congress information.

Q: When will I need to be tested?
A: All meeting delegates must be tested by the IGCS COVID team and show a negative test at the time of registration. Testing will be offered at the meeting venue on Sunday, August 29, 2021 and will remain available throughout the conference.

Q: Is IGCS testing required if I recently completed testing somewhere else?
A: Yes, the test done by IGCS is required. COVID tests that have been done elsewhere and Green passes issued in the EU will not be accepted to grant access to the Congress. All delegates must have a negative test performed by the IGCS team at the venue. IGCS is covering the cost of the required COVID test for entry.

Q: What if I am not in Rome on August 29th to get tested by the IGCS team?
A: Testing stations will be available throughout the duration of the meeting.

Q: What happens if I test positive for COVID-19?
A: If a delegate tests positive for COVID-19, a molecular PCR test will be issued. If found positive, the delegate will not be allowed to enter the auditorium and will be advised on safe transportation from the auditorium to their hotel. The IGCS COVID team will provide them with information and assistance on local medical care and further testing facilities as needed. Note that any required PCR testing and transportation away from the venue will be at the expense of the delegate. The delegate will receive a registration conversion from an in-person pass to a virtual pass and will receive the appropriate refund in price in adherence to the IGCS registration conversion and cancellation policy.

Q: What are the current safety measures in place at The Auditorium?
A: The Auditorium has provided detailed safety measures that will be shared with delegates attending in-person in advance of the meeting. At this time, guidelines include but are not limited to:

  • Temperature checks upon entering the Auditorium.
  • All those entering the Auditorium will be required to wear an FFP2 face mask at all times while in the Auditorium.   
  • Seating within the halls has been spaced to adhere to social distance guidelines, currently 1m. A maximum of 500 delegates will be allowed.
  • Notices stating safety regulations to be followed, aimed principally at the audience, will be displayed at various points inside the Auditorium.

Q: Is there any information that I need to be aware of regarding COVID-19 and travel?
A: Click here for important information from the Italian Ministry of Health regarding travel and COVID-19. This includes specific information about the classification of territories, travel restrictions, rules, and requirements for travelling to and from abroad.

Dr. Chege Completes IGCS Curriculum

Congratulations to Dr. Henry Chege from Moi University in Kenya for completing the IGCS Gynecologic Oncology Global Curriculum & Mentorship Program!

Dr. Henry Chege
Moi University, Kenya

“I thank all of you for the support you accorded me during the IGCS fellowship training. To the international mentors Prof. Barry and Prof. Al Covens, thank you for taking time to travel all the way to Kenya to supervise the training. I will always be indebted to these great mentors.”

This fellowship program is the first fellowship in any medical field approved by Moi University. The IGCS Global Curriculum was established in 2017 under the leadership of then-President, Michael Quinn. It is a comprehensive two-year education and training program designed for regions around the world that do not currently have formal training in gynecologic oncology. Click here to learn more about the program.

Congratulations to Dr. Chege on achieving this important milestone. Many thanks to the local and international mentors for their support and guidance.

Local Mentors

Dr. Benjamin Elly
Moi University
Kenya

Dr. Peter Itsura
Moi University
Kenya

Dr. Omenge Orango
Moi University
Kenya

International Mentors

Dr. Barry Rosen
Beaumont Gynecologic Oncology
USA

Dr. Al Covens
Sunnybrook Health Sciences Centre
The University of Toronto
Canada

Dr. Barry Rosen, International Mentor congratulates Dr. Chege: "You made a very impressive, total commitment Henry, giving up your clinic practice, giving up money you would have made to do this training. And you had delays (out of your control) along the way which must have been very frustrating. It is a very big accomplishment. You are now internationally recognized for your expertise. Kenyan women will benefit so much from your expertise and your future training of other doctors. I wish I could be in Kenya to congratulate you in person.”

Volunteer to Support IGCS Mentorship & Training Programs

We are always looking for volunteer leaders of all disciplines to support our mentorship and training programs. If you are interested in becoming a mentor or contributing to our virtual tumor boards, please contact Susan Ralph at susan.ralph@igcs.org.

IGCS 2021 Registration Options

In this video message, Scientific Program Committee Co-Chair, Dr. Matthew Powell, describes the multiple ways you can register for IGCS 2021.

Whether you choose to attend the Annual Meeting in Rome, virtually, or by gathering locally, IGCS 2021 is a great opportunity to expand your professional network and collaborate with colleagues from around the world.

Register for IGCS 2021

Group Registration 

 

Did you miss our last video message?
View Dr. Coleman’s video message regarding the Presidential Plenary at IGCS 2021.

Breast Cancer Course

International Course on Breast Cancer
Three-Part Webinar Series

Associate Professor: Dr. Víctor Manuel Vargas Hernández

Adjunct Professors:
Dr. Guillermo Sídney Herbert Núñez
Dr. David Cantú de León

Coordinators:
Dr. Antonio Posada Domínguez
Dr. Paula Anel Cabrera
Dr. José Hinojosa Gómez

Descargar el Programa (Español)

 

Parte 1: Diagnósticos
Grabado el 27 de Marzo de 2021


Parte 2: Tratamiento Quirúrgico y Quimioterápico
Grabado el 24 de Abril de 2021


Parte 3: Tratamiento de Radioterapia
Grabado el 29 de Mayo de 2021

Garima Yadav Member Spotlight

IGCS offers members the opportunity to share their stories with the greater gynecologic oncology community, inspire care givers around the world and strengthen awareness of the profession and society. IGCS Member Spotlights highlight the achievements, contributions, and personal stories of members within the worldwide women’s cancer care community.

Meet Garima Yadav, an IGCS Member and Associate Professor at the All India Institute of Medical Sciences in Jodhpur, India.

Where did you complete your training? Or tell us about your background in gyn oncology.
I completed my training at the University College of Medical Sciences in Delhi and Tata Memorial Centre in Mumbai, India. Since 2018, I have been working in the field of gynecologic oncology in a tertiary care centre in western Rajasthan.

Why did you decide to pursue a career in gyn oncology or what about it interested you?
During my residency, I had the fortune of working in the busiest referral hospital in the capitol of India and saw women with gynecological cancers from all over the country. The multidisciplinary management, fascinating surgeries and overall caring for these women attracted me to this field.

Tell us about your work in women’s cancer: daily activities and/or special projects.
I am presently working at a tertiary referral centre in western Rajasthan with state of the art patient care. I am regularly conducting awareness classes for our women about breast and gynecological malignancies. Along with this, we are involved in screening women for cervical cancers, all kinds of pre-invasive cancer diagnosis and treatment. We operate on all kinds of early and advanced stage gynecological malignancies 3-4 times a week and conduct a weekly follow up clinic. I am also an active executive member of the Rajasthan state chapter of Association of Gynecologic oncologists of India (AGOI).

Tell us about the person or people who have inspired you the most in your career.
There are many renowned gynecologic oncologists from India and abroad whom I dearly look up to like my teachers Dr. Shalini Rajaram, Dr. Amita Maheshwari and Dr. Pratibha Singh. I was highly inspired by Dr. Pedro T. Ramirez when I heard him discussing LACC trial results at the 2018 IGCS Annual Meeting in Kyoto, Japan…Click here to read more 

You Could be Next in the Spotlight! To be featured in the IGCS Member Spotlight, please complete a brief questionnaire to tell us more about yourself and what its like to practice gynecologic oncology in your part of the world. We would love to hear your story.  Complete the questionnaire and read other member highlights here

Global Curriculum Graduates

IGCS Members and Friends,

We are incredibly proud of these newly trained gynecologic oncology professionals and grateful to the international mentors and local faculty who worked so hard to implement the curriculum. This program is directly aligned with the IGCS Global Health Equity Statement by supporting the training of gynecologic cancer specialists in disparate areas of the world. The Global Curriculum is meant to serve as a capacity-building initiative, investing in the effectiveness and future sustainability of each individual training program.

The Global Curriculum was established in 2017 under the leadership of then-President, Michael Quinn. It is a comprehensive two-year education and training program designed for regions around the world that do not currently have formal training in gynecologic oncology. Click here to learn more about the program. Dr. Quinn had this to say, “An outstanding achievement during these difficult times. Many congratulations to the graduates and to all those involved in their teaching and assessment programs.’

The IGCS fellows are the future leaders and champions of women’s health in their regions. Cervical cancer is the leading cause of cancer-related death for women in low-resource settings and women in these regions are often diagnosed in advanced stages when it is difficult to treat. The World Health Organization (WHO) in 2018 released a global call for action towards the elimination of cervical cancer as a global public health problem. The goals of the call to action include HPV vaccination, screening and treatment of pre-cancer, early detection and prompt treatment of early invasive cancers and palliative care, when a cure is not possible.

With the support and weight of the IGCS behind them, these IGCS Fellows have the training and ambition to make a huge impact to reduce the burden of cervical cancer at the local level. Their training not only provides the skills to manage comprehensive patient care, but to encourage changes in health policies and collect data for their local governments to advocate for screening and vaccination programs. IGCS is committed to engage these graduates, support their professional development, and see them become the future leaders of our society.

Want to get involved or learn more?
We are always looking for volunteer leaders of all disciplines to support our mentorship and training programs. If you are interested in becoming a mentor or contributing to our virtual tumor boards, please contact Susan Ralph at susan.ralph@igcs.org. Learn more about IGCS’s mentorship and training initiatives on the next episode of Conversations with Coleman, a Presidential Web Series. The date will be announced soon.

Please join us in congratulating them on their achievement!

Sincerely,

Kathleen Schmeler, MD
IGCS Mentorship & Training Committee Chair

Joseph Ng, MD
IGCS Mentorship & Training Committee Vice Chair

Dr. Bethel Dereje
St. Paul’s Hospital Millennium Medical College, Ethiopia
Fellowship Training Completed: 2021

“I would like to pass my gratitude to all the IGCS team who supported the global program from inception to this date. Your determination has brought a change in the care of gynecologic cancer in the developing world. My heart felt gratitude goes to my mentors Carolyn Johnston and Rahel Ghebre for their unwavering support and commitment to strengthen our program.”

Dr. Dawit Worku
Black Lion Hospital, Ethiopia
Fellowship Training Completed: 2021

“It is an honor and privilege to be part of the IGCS fellowship program. I would like to thank my mentors and the IGCS team who have been instrumental for this program. I am looking forward to continued collaboration in fight against gynecologic cancer. Thank you!”

Dr. Eric Estrada
Hospital General San Juan de Dios, Guatemala
Fellowship Training Completed: 2021

“I have no words to describe the feeling at this moment. Thrilled, excited and happy but definitely committed more than ever to continue toward improving Women’s Health in my country. Thank you to each one of you who took the time to teach me and open the doors to improve my life and the ones who will benefit from this gained knowledge that I have. I want to thank Julio Lau and Rene Pareja for all the effort and time they spend with me during my training and also my family who joined me in this journey.”

Dr. Quynh Tran
Da Nang Oncology Hospital, Vietnam
Fellowship Training Completed: 2021

“Thank you for always believing and supporting me, mentors. Thank you the IGCS staff. I am so honored and thankful to be a fellow of IGCS. You raise me up to more than I can be.”

Saujanya Karmacharya
Civil Service Hospital Nepal
Fellowship Training Completed: 2021

“Joining IGCS Fellowship program was a great turning point in my life. It has made me realize that a dream doesn’t become reality through magic, it takes sweat, determination and hard work. I am honored to be first trained fellow of IGCS in whole South East Asia. This fellowship has enriched my knowledge and skills in gynecologic oncology. It has changed my thoughts and approach while managing gynecologic cancer patients. It has taught me to work in a team, respect each other’s opinion for a common cause and how team effort helps to benefit in patient management.

I extend my sincere gratitude to my local mentor Dr Jitendra Pariyar, International mentors Dr. Asima Mukhopadhaya (U.K) and Dr. Linus Chuang (U.S) who have put so much effort and time to impart us with knowledge and skills during fellowship training. I am grateful to Prof. Kathleen Schmeler, Dr. Thomas Randall, Dr. Joseph Ng, Mary Eiken, and Susan Ralph – IGCS leadership team for extensive support required during program. I am beholden by the hospitality and experiences shared by Consultants, fellow colleagues and staffs of Queen Elizabeth Hospital, Gateshead, U.K and TATA Medical Center, Kolkata, India during my international site posting. I will always cherish the moment shared with our Multidisciplinary team of Civil Service Hospital, Nepal, national and International faculties during discussions/ tumor boards regarding management of cancer patients. The bond we share will always remain for welfare of gynecologic cancer patients. I would like to thank all departments of Civil Service Hospital, Clinical Oncology department of (National Academy of Medical Science) Bir Hospital, Kathmandu Cancer Center and National Cancer hospital for their support and encouragement for the fellowship program. In every step of my life, I praise my family for being my backbone. In addition, I am grateful to all patients for their trust and faith in us and also teaching us to never lose hope in life, just keep on believing.

I am excited to set up gynecologic oncology services at large for welfare of women’s health with your guidance and support. I am planning to implement cancer prevention strategies, improve the capacity to make accurate cancer diagnosis, enhance provision of treatment (including palliative care) and research.”

 

Sentiments of Congratulations from the Mentors and Supervisors

ETHIOPIA
Dr. Rahel Ghebre – International Mentor for Drs. Bethel Dereje and Dawit Worku
“I am honored to officially welcome Drs. Bethel Dereje and Dawit Kassa into this great profession of gynecologic oncology. I have witnessed their dedication and fortitude in the daily struggle to care for the many women diagnosed with gynecologic cancers in Ethiopia; providing cancer care in a limited resource setting requires knowledge, skill, and courage. The IGCS global fellowship program provided them the opportunity for training and the credit goes to both graduating fellows and their local mentors for successfully completing the program. I thank them and our colleagues in Ethiopia for the honor to be part of their training.”

Dr. Carolyn Johnston- International Mentor for Drs. Bethel Dereje and Dawit Worku
“I am humbled and pleased to have been a part of Bethel’s and Dawit’s IGCS gynecologic oncology fellowship training. Their energy and enthusiasm for knowledge and skill acquisition is fun. The women of Ethiopia are fortunate to have their help. Congratulations to them and their local mentors for their successes.”

GUATEMALA
Dr. Rene Pareja – International Mentor for Dr. Erick Estrada
“Congrats Erick! Thank you so much to those that made this possible. IGCS administrative staff, Susan, Tom, Al, Kathleen, Linus, Mary, Julio, end the rest of the team that everyday work so hard in order to improve the quality of care we give to underserved women. I am really proud on being part of Global Curriculum. Happy to belong to IGCS Family!!”

Dr. Julio Lau de la Vega – Local Mentor for Dr. Erick Estrada
“Since I met Erick as a medical student, he has been an example of dedication and perseverance. He is a model for the next generation of gynecologist. I so proud that he completed the IGCS gynecologic oncology program, he will be a leader in my country against women’s cancer.”

VIETNAM

Dr. Tri Dinh (USA) – International Mentor for Dr. Quynh Tran
“Quynh is now the first graduate of the only gyn oncology fellowship in SE Asia. This is the culmination of 3 years of hard work on Quynh’s part and dedication on the part of her mentors (both inside and outside of Vietnam), the IGCS staff, and all the participants on the Da Nang tumor board. My thanks to all of you and I am grateful to Quynh to take on this great journey with us. This coming weekend is the Lunar New Year or “Tet” in Vietnam. This is a great present for us all.”

Dr. Tu Quy Tran – local Mentor for Dr. Quynh Tran
“On behalf of our hospital, I would like to say Thank you to all members of IGCS that gives us the opportunities to enhance our practical’s on gynecologic oncology. Also, we are thankful to Drs. Linda, Tri and Joe who always support and teach Quynh how to do the right things in her journey. Hopefully, we can continue this training program in the future with Ngoc and other fellows in Danang as strong as we expected.”

Dr. Joseph Ng -International Mentor for Dr. Quynh Tran
“Dr Quynh TRAN was the very first fellow in the IGCS Global Curriculum in Gyn Oncology Training program. The program itself was part of a pilot of 5 global sites and the only one in Asia when we started Dr TRAN’s training journey. Personally, reflecting on this momentous occasion of the successful graduation of the IGCS Global Curriculum at Danang’s first fellow and now newly minted global Gynecologic oncologist, I am struck by how interconnected all of us are. We are connected by our humanity, by our need to salve hurt in sickness, by our hope in effort, by our need to strive to do better. I am also reminded of just how Quynh embodies all these humane qualities and how the program has helped her develop these qualities in the service of the women living with cancer in Central Vietnam.”

NEPAL
Dr. Linus Chuang – International Mentor for Dr. Saujanya Karmacharya
“I am truly honored to have the opportunity to work with Dr. Pariya and Mukhopadhyay mentoring Dr. Karmacharya throughout her two years of training. It is great to witness her blossoming into a trained gynecologic oncologist.”

Dr. Jitendra Pariyar -Local Mentor for Dr. Saujanya Karmacharya
Huge congratulations to Dr. Saujanya on her achievement: successful completion of the IGCS Gynecologic Oncology Fellowship as the first fellow from Nepal. It is indeed a happy and a moment of pride for all of us. On behalf of Nepal Site, I would like to express my sincere gratitude to Dr. Asima and Prof. Linus for their mentorship and guardianship to us all. Their kind guidance, support and dedicated teachings to our fellows are reflected in our fellows’ performance and Dr. Saujanya’s present result. Thank you Prof. Kathleen, Dr. Thomas, Dr. Joseph – IGCS leadership team for offering the much needed gynecologic oncology fellowship program to Nepal. The program aimed to to provide training opportunities in gynecologic oncology has also helped in upgrading our oncology services. With your continuous support we wish to carry on program for better service of the needy women suffering from gynecologic cancers as envisioned by IGCS. Thank you Susan and Mary for your support and assistance. We would also like to extend our gratitude to all the national and international faculties for their support and valuable contribution to our program and training of our fellows!

Dr. Asima Mukhopadhyay – International Mentor for Dr. Saujanya Karmacharya
“I am very proud to be associated with this great education program initiative. Congratulations to Saujanya and local mentor Jitendra and the entire Nepal team for excelling in their effort to make this a success. I sincerely hope that IGCS training curriculum can be followed in many other regional cancer centres where formal training program for Gyn Oncology is not established.”

COVID-19 Resource Center

COVID-19 Resources & Reading

The NIHR Global Health Research Unit on Global Surgery is conducting a CovidSurg Cancer Study to better understand the impact of COVID-19 on care of Cancer Patients requiring surgery. Learn more about the inclusion criteria. 

IGCS is making available a list of materials and resources related to the COVID-19 emergency, but no content provided at these links is either proprietory of or endorsed by IGCS.

Latin America Webinar 2020


Recorded Sábado, Diciembre 5, 2020
A recording of this webinar is available to IGCS Members in the Education Portal.

Course Objectives

  • To understand the current status of surgical options in ovarian cancer.
  • To update the current indications of Neo-adjuvant chemotherapy in cervical cancer.

Moderators

Clemente Arab, MD
Instituto Oncológico FALP
Chile

Magaly Malca, MD
Hospital Edgardo Rebagliati Martins
Perú

Speakers

Ovarian Cancer

Pedro Ramirez, MD 
The University of Texas – MD Anderson Cancer Center
USA

What is new in surgical treatment of ovarian cancer

 

Reitan Ribeiro, MD
Erasto Gaertner Hospital
Brazil 

… What if TRUST trial has a positive result?

 

Alejandro Rauh-Hain, MD
The University of Texas – MD Anderson Cancer Center
USA

… What if TRUST trial has a negative result?

 

Cervix Cancer

Myriam Perrotta, MD 
Hospital Italiano de Buenos Aires
Argentina

Impact of the HPV vaccination on cervical cancer mortality

 

Juliana Rodriguez, MD
Instituto Nacional de Cancerología
Colombia

Neo-adjuvant chemotherapy in pregnant women with cervical cancer

 

Fabio Martinelli, MD 
Fondazione IRCCS Istituto Nazionale dei Tumori
Italy 

Neo-adjuvant chemotherapy in cervical cancer state-of-the-art

 


René Pareja, MD
Instituto Nacional de Cancerología-Bogota; Clínica de Oncología Astorga-Medellín
Colombia

Neo-adjuvant chemotherapy and fertility preservation in cervical cancer

 

Descargar Agenda (Espanol) Download Agenda (English)

 

Education Highlight: Pathology Corner Resources

Education Highlight: New Pathology Corner Resources

Login to the IGCS Education Portal to access new resources recently uploaded in the Pathology Corner:

  • WHO Classifications of Female Genital Tumors – 5th Edition Update
    • Download comprehensive summaries of the 5th edition update of the WHO Blue Books created by members of the IGCS Pathology Work Group for cervix, ovary, uterine, vulvar, and vaginal cancers.
  • Literature Highlights: Four new articles have been uploaded in addition to the summaries of papers from ISGyP’s Endometrial Carcinoma Project published in the International Journal of Gynecological Pathology.
    • Uterine Endometrial Stromal Tumors with Limited Infiltration: First Report of a Case Series Indicating Potential for Malignant Behavior
    • Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer
    • Molecular Subtypes of Clear Cell Carcinoma if the Endometrium: Opportunities for Prognostic and Predictive Stratification
    • Mismatch Repair Deficiency and Prognostic Significance in Patients with Low-Risk Endometrioid Endometrial Cancers
  • Interesting Cases: Two case reviews are now available with images and descriptions diagnosing:
    • Struma Ovarii
    • Papillary Thyroid Carcinoma Arising in Mature Cystic Teratoma

While you are exploring the Pathology Corner, make sure to view the educational lectures, download the terms & definitions of commonly used IHC stains in gynecologic oncology and please feel free to send an email to pathology@igcs.org to submit your pathology-related questions to the IGCS Pathology Work Group members.

Under the direction of Anna Plotkin, Pathology Work Group Lead, and with significant contributions from our Strategic Alliance Partner Members at the International Society of Gynecological Pathologists (ISGyP), the corner was created to streamline pathology related education curated specifically for gynecologic oncologists. We would like to acknowledge and express gratitude to our work group members for their efforts: Anna Plotkin, Work Group Lead (Canada), Blake Gilks (Canada), Siobhan O’Connor (USA), Joseph Rabban (USA), Adrian Suarez (USA), Gulisa Turashvili (Canada), and Rachael van der Griend (New Zealand) and all the contributors who have agreed to share content.

We hope you enjoy the new educational content in the Pathology Corner of the IGCS Member Education Portal!